| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |